Clinical significance and biological role of L1 cell adhesion molecule in gastric cancer

1. Kamangar, F., Dores, G. M. & Anderson, W. F. Patterns of cancer incidence,

mortality, and prevalence across five continents: defining priorities to reduce

cancer disparities in different geographic regions of the world. J. Clin. Oncol. Off.

J. Am. Soc. Clin. Oncol. 24, 2137–2150 (2006).

2. Garcia, MJA W. E. Global Cancer Facts and Figures (2007).

3. Schachner, M. Neural recognition molecules and synaptic plasticity. Curr. Opin.

Cell Biol. 9, 627–634 (1997).

4. Kamiguchi, H., Hlavin, M. L. & Lemmon, V. Role of L1 in neural development: what

the knockouts tell us. Mol. Cell. Neurosci. 12, 48–55 (1998).

5. Brummendorf, T., Kenwrick, S. & Rathjen, F. G. Neural cell recognition molecule

L1: from cell biology to human hereditary brain malformations. Curr. Opin. Neurobiol. 8, 87–97 (1998).

6. Hortsch, M. Structural and functional evolution of the L1 family: are four adhesion

molecules better than one? Mol. Cell. Neurosci. 15, 1–10 (2000).

7. Ohnishi, T., Matsumura, H., Izumoto, S., Hiraga, S. & Hayakawa, T. A novel model of

glioma cell invasion using organotypic brain slice culture. Cancer Res. 58,

2935–2940 (1998).

8. Mechtersheimer, S., Gutwein, Agmon-Levin, N., Stoeck, A., Oleszewski, M., Riedle,

S. et al. Ectodomain shedding of L1 adhesion molecule promotes cell migration

by autocrine binding to integrins. J. Cell Biol. 155, 661–673 (2001).

9. Montgomery, A. M., Becker, J. C., Siu, C. H., Lemmon, V. P., Cheresh, D. A., Pancook,

J. D. et al. Human neural cell adhesion molecule L1 and rat homologue NILE are

ligands for integrin alpha v beta 3. J. Cell Biol. 132, 475–485 (1996).

10. Huszar, M., Pfeifer, M., Schirmer, U., Kiefel, H., Konecny, G. E., Ben-Arie, A. et al. Upregulation of L1CAM is linked to loss of hormone receptors and E-cadherin in

aggressive subtypes of endometrial carcinomas. J. Pathol. 220, 551–561, https://

doi.org/10.1002/path.2673 (2010).

11. Geismann, C., Morscheck, M., Koch, D., Bergmann, F., Ungefroren, H., Arlt, A. et al.

Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor

beta1- and slug-dependent: role in malignant transformation of pancreatic

cancer. Cancer Res. 69, 4517–4526 (2009).

12. Okugawa, Y., Tanaka, K., Inoue, Y., Kawamura, M., Kawamoto, A., Hiro, J. et al.

Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in

gastric cancer. Br. J. Cancer 108, 121–130 (2013).

13. Mori, K., Toiyama, Y., Otake, K., Ide, S., Imaoka, H., Okigami, M. et al. Successful

identification of a predictive biomarker for lymph node metastasis in colorectal

cancer using a proteomic approach. Oncotarget 8, 106935–106947 (2017).

14. Okugawa, Y., Toiyama, Y., Hur, K., Toden, S., Saigusa, S., Tanaka, K. et al.

Metastasis-associated long non-coding RNA drives gastric cancer development

and promotes peritoneal metastasis. Carcinogenesis 35, 2731–2739 (2014).

15. Toiyama, Y., Inoue, Y., Yasuda, H., Saigusa, S., Yokoe, T., Okugawa, Y. et al. DPEP1,

expressed in the early stages of colon carcinogenesis, affects cancer cell invasiveness. J. Gastroenterol. 46, 153–163 (2011).

16. Okugawa, Y., Toiyama, Y., Ichikawa, T., Kawamura, M., Yasuda, H., Fujikawa, H.

et al. Colony-stimulating factor-1 and colony-stimulating factor-1 receptor coexpression is associated with disease progression in gastric cancer. Int. J. Oncol.

53, 737–749 (2018).

17. Okugawa, Y., Toiyama, Y., Toden, S., Mitoma, H., Nagasaka, T., Tanaka, K. et al.

Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in

colorectal cancer. Gut 66, 107–117 (2017).

Clinical significance and biological role of L1 cell adhesion molecule in. . .

T Ichikawa et al.

1068

18. Walsh, A. M., Kapoor, G. S., Buonato, J. M., Mathew, L. K., Bi, Y., Davuluri, R. V. et al.

Sprouty2 drives drug resistance and proliferation in glioblastoma. Mol. Cancer

Res. 13, 1227–1237 (2015).

19. Workman, Aboagye, E. O., Balkwill, F., Balmain, A., Bruder, G., Chaplin, D. J. et al.

Guidelines for the welfare and use of animals in cancer research. Br. J. Cancer 102,

1555–1577 (2010).

20. Austin, P. C. An introduction to propensity score methods for reducing the effects

of confounding in observational studies. Multivar. Behav. Res. 46, 399–424 (2011).

21. Frisch, S. M. & Francis, H. Disruption of epithelial cell-matrix interactions induces

apoptosis. J. Cell Biol. 124, 619–626 (1994).

22. Eccles, S. A. & Welch, D. R. Metastasis: recent discoveries and novel treatment

strategies. Lancet (Lond., Engl.) 369, 1742–1757 (2007).

23. Vizza, E., Mancini, E., Laquintana, V., Loria, R., Carosi, M., Baiocco, E. et al. The

prognostic significance of positive peritoneal cytology in endometrial cancer and

its correlations with L1-CAM biomarker. Surg. Oncol. 28, 151–157 (2019).

24. de Freitas, D., Aguiar, F. N., Anton, C., Bacchi, C. E., Carvalho, J. P. & Carvalho, F. M.

L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial

carcinomas: a possible pre-operative surrogate of lymph vascular space invasion.

PloS ONE 13, e0209294 (2018).

25. Wachowiak, R., Krause, M., Mayer, S., Peukert, N., Suttkus, A., Muller, W. C. et al.

Increased L1CAM (CD171) levels are associated with glioblastoma and metastatic

brain tumors. Medicine 97, e12396 (2018).

26. Na’ara, S., Amit, M. & Gil, Z. L1CAM induces perineural invasion of pancreas cancer

cells by upregulation of metalloproteinase expression. Oncogene 38, 596–608 (2019).

27. Versluis, M., Plat, A., de Bruyn, M., Matias-Guiu, X., Trovic, J., Krakstad, C. et al.

L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition. Virchows

Archiv. Int. J. Pathol. 473, 591–598 (2018).

28. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 63,

11–30(2013).

29. Gupta, G. P. & Massague, J. Cancer metastasis: building a framework. Cell 127,

679–695 (2006).

30. Zhou, Y., Zhang, G. J., Wang, J., Zheng, K. Y. & Fu, W. Current status of lymph node

micrometastasis in gastric cancer. Oncotarget 8, 51963–51969 (2017).

31. Tischler, V., Pfeifer, M., Hausladen, S., Schirmer, U., Bonde, A. K., Kristiansen, G.

et al. L1CAM protein expression is associated with poor prognosis in non-small

cell lung cancer. Mol. Cancer 10, 127 (2011).

32. Hai, J., Zhu, C. Q., Bandarchi, B., Wang, Y. H., Navab, R., Shepherd, F. A. et al. L1 cell

adhesion molecule promotes tumorigenicity and metastatic potential in nonsmall cell lung cancer. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 18,

1914–1924 (2012).

33. Mohanan, V., Temburni, M. K., Kappes, J. C. & Galileo, D. S. L1CAM stimulates

glioma cell motility and proliferation through the fibroblast growth factor

receptor. Clin. Exp. Metastasis 30, 507–520 (2013).

34. Zhang, J., Yang, F., Ding, Y., Zhen, L., Han, X., Jiao, F. et al. Overexpression of L1

cell adhesion molecule correlates with aggressive tumor progression of patients

with breast cancer and promotes motility of breast cancer cells. Int. J. Clin. Exp.

Pathol. 8, 9240–9247 (2015).

...